Target Condition | Study | Reference Standard | Sensitivity | Specificity | LR+ | LR- |
---|---|---|---|---|---|---|
 | Systematic Review |  |  |  |  |  |
CTS | Cartwright 2012 [81] | Clinical and NCS | 0.65–1.00 | 0.50–0.98 | 1.66–48.5 | 0.00–0.38 |
 | Descatha 2012 [82] | Clinical and NCS | 0.84 | 0.78 | 3.82 | 0.21 |
 | Roll 2011 [83] | Clinical and NCS | 0.29 to 1.00 | 0.47 to 1.00 | 1.89–∞ | 0.00–0.71 |
 | Beekman 2003 [80] | NCS | 0.70–0.88 | 0.57–0.96 | 1.70–27.3 | 0.13–0.48 |
 | Diagnostic Study |  |  |  |  |  |
 | Deniz 2012 [84] | Clinical and NCS | 0.84 | 0.79 | 4.00 | 0.20 |
 | Kim 2012 [85] | Clinical and NCS | 0.89 | 0.90 | 8.90 | 0.12 |
 | Moghtaderi 2012 [86] | Clinical and NCS | 0.83 | 0.91 | 9.22 | 0.19 |
 | Ooi 2014 [87] | NCS | 0.92 | 0.90 | 9.20 | 0.09 |
 | Tajika 2013 [88] | NCS | 1.00 | 0.99 | 100 | - |
Ligament Injury | Â | Â | Â | Â | Â | Â |
 UCL (displaced) | Chuter 2009 [90] | Surgical Findings | 0.92 | N/S | - | - |
 | Hergan 1995 [93] | MRI | 0.88 | 0.83 | 5.18 | 0.15 |
 | Melville 2013 [96] | Surgical Findings | 1.00 | 1.00 | - | - |
 UCL (non-displaced) | Hergan 1995 [93] | MRI | 0.88 | 0.91 | 9.78 | 0.13 |
 | Melville 2013 [96] | Surgical Findings | 1.00 | 1.00 | - | - |
 Scapholunate | Dao 2004 [91] | Arthroscopy | 0.46 | 1.00 | - | 0.54 |
 | Finley 2004 [92] | Arthrography | 1.00 | 1.00 | - | - |
 | Taljanovic 2008 [98] | MRA | 1.00 | 0.92 | 12.5 | - |
 Lunotriquetral | Finley 2004 [92] | Arthrography | 0.25 | 1.00 | - | 0.75 |
 | Taljanovic 2008 [98] | MRA | 0.50 | 0.90 | 5.00 | 0.56 |
 TFCC | Finley 2004 [92] | Arthrography | 0.64 | 1.00 | - | 0.36 |
 | Taljanovic 2008 [98] | MRA | 0.86 | 1.00 | - | 0.14 |
de Quervains | Choi 2011 [89] | Surgical Findings | 1.00 | N/S | - | - |
 | Kwon 2010 [95] | Surgical Findings | 1.00 | 0.96 | 25.0 | - |
Ganglion Cyst | Kuwano 2010 [94] | Surgical Findings | 0.39 | 1.00 | - | 0.61 |
 | Osterwalder 1997 [97] | Histology and surgical findings | 0.93 | 0.86 | 6.64 | 0.08 |